β-agonists are prohibited substances for athletes according to the World Anti-Doping Agency and are banned as growth promoters for livestock in most countries. The illicit use of β-agonists is a significant concern for both human and animal health. Hair analysis serves as a valuable material for monitoring the abuse of β-agonists. This manuscript aims to provide a comprehensive overview of the application of hair analysis in monitoring β-agonist abuse. The morphology, structures, and composition of hair are summarized, along with an introduction to the mechanisms of β-agonist incorporation into hair. Considering various factors, the treatment procedures for β-agonist detection in hair, with special attention to the authentic matrix, are outlined. Additionally, diverse screening and confirmatory methods are reviewed. Particular emphasis is placed on novel purification processes and innovative analytical technologies employed for the analysis of β-agonists in hair.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chroma.2025.465846 | DOI Listing |
Rev Bras Enferm
March 2025
Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil.
Objectives: to evaluate the quality of life and body image in women with breast cancer during chemotherapy, before and after interventions targeting body image.
Methods: we conducted a prospective cohort study with 47 women, utilizing both qualitative and quantitative data analysis.
Results: in the semi-structured interviews, 52.
Early-onset androgenetic alopecia (AGA) is a common, hereditary hair loss condition in men, often starting in the early twenties. It involves gradual thinning of hair, influenced by genetics, hormones, and other factors like smoking and family history. Early identification of these risks could support timely intervention.
View Article and Find Full Text PDFAnim Biotechnol
December 2025
Faculty of Science, Dookie College, The University of Melbourne, Melbourne, Australia.
This study aimed to 1) Establish relationships between feed conversion efficiency (FCE; live weight gain/intake) and several biomarkers in pigs using blood and hair samples, and 2) Investigate the relative FCE performance of pigs from maternal vs. terminal genetic lines fed high vs. low energy diets.
View Article and Find Full Text PDFJ Dermatol
March 2025
Pfizer Japan Inc, Tokyo, Japan.
This subgroup analysis of the ALLEGRO phase 2b/3 study (NCT3732807) assessed the efficacy and safety of multiple doses of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in Asian patients with alopecia areata (AA). Patients aged ≥12 years with AA and ≥50% scalp hair loss received once-daily ritlecitinib 50 or 30 mg (with or without 4-week 200-mg loading dose ["200/50" or "200/30"]) or 10 mg or placebo for 24 weeks, followed by a 24-week extension, in which patients initially assigned to placebo switched to 200/50 or 50 mg. In this subgroup analysis, Asian patients with response based on achieving a Severity of Alopecia Tool (SALT) score ≤20, SALT ≤10, ≥2-grade improvement or normal score on the eyebrow assessment (EBA) scale, and ≥2-grade improvement or normal score on the eyelash assessment (ELA) scale were evaluated through week 48.
View Article and Find Full Text PDFInt J Artif Organs
March 2025
Department of Dental Materials and Prosthodontics, Araçatuba Dental School, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil.
Objective: Therefore, this study aimed to evaluate the maximum displacement resistance of silicone samples adhered to human skin using different adhesives. For this purpose, colorless silicone samples (A-4530-HCRA Silicone Gum HCR) pigmented with Functional Intrinsic II Silicone Coloring System were made and distributed into five groups (1. SA specific adhesive for maxillofacial prostheses: Drying Adhesive; 2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!